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Efficient protein folding and quality control are essential for unperturbed cell viability. Defects in these processes may 
lead to production of aberrant polypeptides that are either degraded leading to “loss-of-function” phenotypes, or 
deposited in or outside cells leading to “gain-of-toxic-function” phenotypes. Elucidation of molecular mechanisms 
regulating folding and quality control of newly synthesized polypeptides is therefore of greatest interest. Here we 
describe protocols for metabolic labelling of transfected/infected mammalian cells with [35S]-methionine and [35S]-
cysteine, for immunoisolation from detergent extracts of the selected model proteins and for the investigation of the 






Secretory proteins, luminal or membrane-associated 
proteins of the endo-exocytic compartments and plasma 
membrane proteins are expressed by ribosomes 
associated with the cytosolic face of the protein-
conducting Sec61 channels in the ER membrane. The 
nascent chains are injected in the ER lumen and their 
folding is assisted by a large number of ER-resident 
molecular chaperones and folding factors (1). The co- 
and post-translational addition of oligosaccharides on 
asparagine residues (N-linked glycosylation (2)) and the 
formation of disulphide bonds covalently linking the 
polypeptide’s cysteines (3) are crucial for acquisition of 
native architecture. Completion of the folding process 
may also involve formation of homo- or heterooligomeric 
complexes that normally precedes release of the native  
 
 
proteins from the ER and transport at their final intra- or 
extracellular destination (4, 5). Protein folding is error-
prone and gene deletions or mutations may further 
reduce folding efficiency. Folding-defective polypeptides 
are retained in the ER lumen. To avoid accumulation of 
these toxic by-products of protein biosynthesis that could 
trigger unfolded protein responses often resulting in cell 
death (6), aberrant polypeptides are eventually 
dislocated back into the cytosol for proteasome-mediated 
degradation (7, 8). This article describes an approach that 
has been instrumental to analyze in living cells the 
molecular mechanisms regulating protein folding and 
disposal, namely, the transient associations of immature 
polypeptides with ER-resident chaperones (9-11) and 
enzymes (12), the formation of intra- and intermolecular 
disulfide bonds as essential steps in the protein folding 
process (13-15), the folding or degradation kinetics in the 
   
 
 




presence of cell permeable inhibitors or in cells depleted 
of selected ER-resident chaperones (16, 17). The approach 
consists of six distinct steps: 1) amplification of the signal 
by highest synthesis of the protein-of-interest (cell 
transfection or infection); 2) metabolic labelling of 
nascent polypeptides expressed in living cells followed 
by incubation in non-radioactive medium to allow 
maturation/degradation of the protein-of-interest to 
proceed (pulse-chase); 3) “freezing” of the labelled 
polypeptides in a state reflecting their situation at given 
times after synthesis (sample alkylation and cell lysis); 
4) isolation of the protein-of-interest or of complexes 
containing protein-of-interest:ER-resident chaperones 
with specific antibodies (immunoprecipitation); 5) 
Electrophoretic analysis of the samples by conventional 
SDS-PAGE or by 6) diagonal SDS-PAGE. 
 
MATERIALS AND METHODS 
 
Cell media: DMEM (Gibco), 10% fetal calf serum (FCS), 
1% penicillin and streptomycin (PS)    
 
PBS: 20 mM sodium dihydrogen orthophosphate, 100 
mM sodium chloride, 80 mM di-sodium hydrogen 
orthophosphate anhydrous, pH 7.4  
 
Transfection media: DMEM (Gibco), 10% FCS, 1% non-
essential amino acids (Gibco), Optimem (Gibco) 
 
Transfection reagent: Lipofectamine™ 2000 (Invitrogen) 
 
Inoculum: Serum-free RPMI (Gibco), 20 mM HEPES pH 
6.8, 0.2% bovine serum albumin (BSA), 10-30 plaque-
forming units (pfu) of virus/cell 
 
MG132 (Inhibits ERAD by inactivation of the cytosolic 
proteasome): Stock 10 mM in DMSO. To be used at a 
final concentration of 50 µM 
 
Kifunensine (Inhibits ERAD by inactivation of the ER 
alpha-mannosidase I): Stock 20 mM in H2O. To be used 
at a final concentration of 100 µM 
 
Starvation medium: DMEM w/o L-methionine, w/o L-
cystine, 50 mM HEPES pH 7.4 
Pulse medium: Starvation medium supplemented with 
0.1 mCi/ml [35S]-methionine and [35S]-cysteine (Redivue 
35S-Promix, Amersham) 
 
Chase medium: DMEM, 50 mM HEPES, 5 mM cysteine, 
5 mM methionine 
 
Stop solution (protein alkylation): 20 mM N-
ethylmaleimide (NEM) in PBS 
 
Protease inhibitors cocktail (CLAP): 5 mg chymostatin, 
5 mg leupeptin, 5 mg antipain, 5 mg pepstatin A in 500 
µl DMSO (stock 1000X) 
 
Phenylmethylsulfonyl fluoride (PMSF): Stock 200 mM 
in isopropanol. To be used at the final concentration of 1 
mM 
 
HBS: 50 mM HEPES, 200 mM NaCl (pH 6.8 and pH 7.4) 
 
Lysis: 2% CHAPS in HBS pH 6.8, 1x CLAP, 20 mM NEM, 
1 mM PMSF 
 
ProteinA-Sepharose beads (PAB): 10% w/v suspension 
of PAB (Sigma-Aldrich) in HBS pH 7.4 
 
Washing Buffer: 0.5% CHAPS in HBS pH 7.4 
 
Sample buffer: 82 mM TRIS, 10.5% Glycerol, 2% SDS, 
0.001% Bromophenol blue, pH 6.8. Sample buffer is 
supplemented with 100 µMfin DTT for reducing gels 
 
Coomassie blue stain: 0.25% Coomassie blue, 50% 
methanol, 7.5% acetic acid 
 
Destain: 20% methanol, 7.5% acetic acid 
 
ImageQuant software: Amersham Biosciences 
 
Film: Eastman Kodak BioMax MR 
 
RESULTS AND DISCUSSION 
 
This article describes a pulse-chase approach used in 
combination with immunoprecipitation and 
conventional or diagonal SDS-PAGE to investigate 
protein folding in the ER and disposal of folding-
   
 
 




defective polypeptides from the ER of mammalian tissue 
culture cells.  
 
Folding of influenza HA in mouse embryonic 
fibroblast 
 
HA is a type I transmembrane glycoprotein with 
multiple folding domains. In infected cells the 
ectodomain is cotranslationally translocated into the ER 
where N-linked glycosylation of nascent chains does 
occur. HA oxidative folding starts co-translationally and 
terminates post-translationally with oxidation of the last 
Cys14-Cys466 disulphide. HA oxidation can be 
monitored by taking advantage of differences in 
electrophoretic mobility in nonreducing SDS-PAGE 
between the native HA form (NT) and forms with an 
incomplete set of disulfide bonds (IT1 and IT2) (13) (Fig. 
1A).  
 
To monitor oxidative phases of HA folding, influenza 
virus infected cells were pulse-labeled for 4 min with 0.1 
mCi/ml [35S]-methionine and [35S]-cysteine and chased 
for 0, 2, 5, 10 or 20 min before alkylation with ice-cold 
PBS-NEM and lysis with 2% CHAPS in HBS for 
preparation of the PNS. Cell lysates were supplemented 
with a polyclonal antibody that binds all oxidation forms 
of HA and also cross-reacts with the nuclear protein of 
influenza virus (NP, Fig. 1B). At 0 min chase HA equally 
populated the IT1 and IT2 intermediate forms and the 
NT form (Fig. 1B). With progression of the chase time, 
IT1 and IT2 were gradually converted in the NT form. 
The oxidative folding of HA was virtually terminated 
after a 10 min chase, when most labelled HA had 
acquired the native conformation. In the reducing gel, 
the information about the oxidative state of HA during 
the chase is lost. Intramolecular disulfides are in fact 
reduced by the DTT in the sample buffer so that HA 
migrates as a single polypeptide band (Fig. 1B, R).  
 
The ER lectin calnexin (Cnx) associates transiently with 
monoglucosylated glycoproteins expressed in the lumen 
of the ER, thereby facilitating their maturation (4). To 
monitor transient association of HA with Cnx, the PNS 
were immunoprecipitated with a polyclonal antibody 
raised to the cytosolic tail of Cnx. Labelled Cnx has the 
same intensity in all lanes of the gel (Fig. 1C), the amount 
of labelled chaperone in the cell extracts was in fact the 
same throughout the chase. On the other hand, the 
amount of labelled cellular (arrowheads) and viral (HA) 
glycoproteins co-precipitated with Cnx decreased with 
progression of the chase. Association of Cnx with 
substrates is in fact transient, native polypeptides being 
eventually released from the chaperone to be transported 
along the secretory line to their final destination.   
 
 
Fig. 1: Folding and association of influenza HA with calnexin. A. 
Schematics of major disulfide-bonds in influenza virus HA. Disulfides 
between cysteines 52-277 and cysteines 14-466 close two big loops. The 
NT form contains a full set of disulfides covalently linking the twelve HA 
cysteines, IT2 lacks the disulfide between cysteines 14 and 466, IT1 lacks 
both 52-277 and 14-466 disulfides. B. Oxidative HA folding analyzed in 
conventional SDS-PAGE under nonreducing and reducing conditions. C. 
Transient association of cellular (arrowheads) and viral (HA) glycoproteins 
with Cnx. D. Analysis of co-translational HA oxidation in diagonal SDS-
PAGE. 
 
Co-translational oxidation of HA was also analyzed in 
diagonal gels. Cells infected with influenza virus were 
pulse-labelled for 2.5 min with 0.5 mCi/ml [35S]-
methionine and [35S]-cysteine. The pulse was interrupted 
by transferring dishes on ice and by a wash with the stop 
solution. PNS was immunoprecipitated with a polyclonal 
antibody to HA and analyzed by diagonal SDS-PAGE 
(Fig. 1D). Nascent HA chains were seen as a stripe of 
radioactivity from the lower-left corner (low molecular 
weight) to the upper-right corner (longer HA chains). 
Polypeptides without disulfide bonds ran on the gel 
   
 
 




diagonal, those with intramolecular disulfides (e.g. full-
length IT1, IT2 and NT) ran below the diagonal. The NP 
protein does not contain disulfides and, accordingly, it 
migrated on the gel diagonal. The presence of nascent 
chains below the diagonal clearly showed that formation 
of intramolecular disulfides started before completion of 
HA synthesis (Fig. 1D). 
 
ERAD of BACE457∆ in mouse embryonic fibroblast 
 
Folding-defective polypeptides such as the variant of 
beta secretase expressed in the human pancreas 
(BACE457Δ, (22)) are rapidly degraded to avoid 
accumulation of toxic protein aggregates in the ER 
lumen. To this end, they are translocated into the cytosol 
for proteasome-mediated proteolysis (7, 8). To determine 
kinetics of degradation of BACE, cells were transiently 
transfected with a BACE expression plasmid, pulse-
labelled for 10 min and chased for different times. The 
PNS were immunoprecipitated with a specific antibody 
to BACE. The nonreducing gel showed that cellular 
BACE was in different oxidation states. High molecular 
weight disulfide-bonded aggregates (DBA) containing 
misfolded BACE hardly entered the nonreducing 
running gel and were visible at the top of the gel (Fig. 
2A). Monomeric BACE entered in the gel and was clearly 
separated in three distinct oxidation forms (arrows). 
These progressively disappeared during the chase to be 
in part converted in DBA and in part degraded from the 
ER. Sample reduction disassembled DBA and converted 
all oxidation forms of BACE in a single polypeptide band 
(BACE in the reducing gel (Fig. 2A)). 
 
The heterogeneity of BACE conformations makes 
analysis of degradation kinetics in nonreducing gels 
difficult. ERAD kinetics can, on the other hand, precisely 
be quantified in the reducing gel, where BACE migrated 
as a single (Fig. 2A). 
 
Small variations of the experimental procedures 
described above, for example the expression of the model 
proteins in cells exposed to inhibitory compounds or 
depleted of selected molecular chaperones, allows 
establishing the mechanisms of ERAD with identification 
of luminal and cytosolic factors involved. In the example 
shown in Fig. 2B, cell-permeable inhibitors of protein 
degradation from the ER were added in the starvation, 
pulse and chase media to specifically inactivate the 
cytosolic proteasome (MG132 (M)) or the ER alpha-
mannosidase I (kifunensine (K)). Both inhibitors 
substantially delayed degradation of BACE as shown by 
the higher amount of labelled BACE remaining at the 
end of the 90 min chase, thus showing the involvement 
of the proteasome and the importance of mannose 
trimming for ERAD. 
 
 
Fig. 2: Analysis of ER-associated degradation of BACE457∆. A. Labeled 
BACE was in different oxidation states; monomeric BACE entered in the 
nonreducing running gel as 3 distinct oxidation forms (arrows), oligomeric 
BACE remained at the top of the nonreducing gel in disulfide-bonded 
aggregates (DBA). In the reducing gel DBA and the several BACE oxidation 
forms were reduced in a single BACE polypeptide (BACE). The asterisk 
shows non-glycosylated BACE. B. After 90 min chase BACE was efficiently 
degraded (compare the intensity of labeled BACE at 0 (lane 1) and at 90 
min chase (lane 2). MG132 (M) and kifunensine (K) substantially inhibited 
BACE degradation (lanes 3 and 4, respectively). 
 
In summary, we described here experiments in living 
cells designed to investigate molecular mechanisms 
regulating the maturation of folding-competent and the 
degradation of folding-defective polypeptides. These 
investigations rely on enhanced expression of model 
polypeptides obtained by appropriately transfecting or 
infecting mammalian cultured cells. The fate of the 
radioactively labelled, newly synthesized, model 
proteins is monitored by conventional or diagonal gel 
electrophoresis. The approaches highlighted in this 
paper can easily be adapted and implemented to 
compare protein fates in cells with a complete set of 
chaperones versus cells deleted of a selected chaperone 
or exposed to substances that inhibit chaperone or 
enzyme activities. 
   
 
 






M.M. is supported by grants from Max Cloetta 
Foundation, Foundation for Research on 
Neurodegenerative Diseases, Swiss National Center of 
Competence in Research on Neural Plasticity and Repair, 





1. Gething MJ, Sambrook J. Protein folding in the cell. 
Nature 1992; 355:33-45. 
2. Parodi AJ. Role of N-oligosaccharide endoplasmic 
reticulum processing reactions in glycoprotein 
folding and degradation. Biochem J 2000; 348:1-13. 
3. Ellgaard L, Ruddock LW. The human protein 
disulphide isomerase family: substrate interactions 
and functional properties. EMBO Rep 2005; 6:28-32. 
4. Ellgaard L, Molinari M, Helenius A. Setting the 
standards: quality control in the secretory pathway. 
Science 1999; 286:1882-1888. 
5. Hebert DN, Garman SC, Molinari M. The glycan 
code of the endoplasmic reticulum: asparagine-
linked carbohydrates as protein maturation and 
quality-control tags. Trends Cell Biol 2005; 15:364-370. 
6. Schroder M, Kaufman RJ. The Mammalian unfolded 
protein response. Annu Rev Biochem 2005; 74:739-789. 
7. Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: 
the long road to destruction. Nat Cell Biol 2005; 7:766-
772. 
8. McCracken AA, Brodsky JL. Evolving questions and 
paradigm shifts in endoplasmic-reticulum-associated 
degradation (ERAD). Bioessays 2003; 25:868-877. 
9. Ou WJ, Cameron PH, Thomas DY, Bergeron JJ. 
Association of folding intermediates of glycoproteins 
with calnexin during protein maturation. Nature 
1993; 364:771-776. 
10. Hammond C, Helenius A. Folding of VSV G protein: 
sequential interaction with BiP and calnexin. Science 
1994; 266:456-458. 
11. Nauseef WM, McCormick SJ, Clark RA. Calreticulin 
functions as a molecular chaperone in the 
biosynthesis of myeloperoxidase. J Biol Chem 1995; 
270:4741-4747. 
12. Molinari M, Helenius A. Glycoproteins form mixed 
disulphides with oxidoreductases during folding in 
living cells. Nature 1999; 402:90-93. 
13. Braakman I, Hoover-Litty H, Wagner KR, Helenius 
A. Folding of influenza hemagglutinin in the 
endoplasmic reticulum. J Cell Biol 1991; 114:401-411. 
14. Chen W, Helenius J, Braakman I, Helenius A. 
Cotranslational folding and calnexin binding during 
glycoprotein synthesis. Proc Natl Acad Sci USA 1995; 
92:6229-6233. 
15. Cabibbo A, Pagani M, Fabbri M, Rocchi M, Farmery 
MR, Bulleid NJ, Sitia R. ERO1-L, a human protein 
that favors disulfide bond formation in the 
endoplasmic reticulum. J Biol Chem 2000; 275:4827-
4833. 
16. Liu Y, Choudhury P, Cabral CM, Sifers RN. 
Oligosaccharide modification in the early secretory 
pathway directs the selection of a misfolded 
glycoprotein for degradation by the proteasome. J 
Biol Chem 1999; 274:5861-5867. 
17. Molinari M, Eriksson KK, Calanca V, Galli C, 
Cresswell P, Michalak M, Helenius A. Contrasting 
Functions of Calreticulin and Calnexin in 
Glycoprotein Folding and ER Quality Control. Mol 
Cell 2004; 13:125-135. 
18. Gallione CJ, Rose JK. A single amino acid 
substitution in a hydrophobic domain causes 
temperature-sensitive cell-surface transport of a 
mutant viral glycoprotein. J Virol 1985; 54:374-382. 
19. Helenius A, Simons K. Solubilization of membranes 
by detergents. Biochim Biophys Acta 1975; 415:29-79. 
20. Sommer A, Traut RR. Diagonal polyacrylamide-
dodecyl sulfate gel electrophoresis for the 
identification of ribosomal proteins crosslinked with 
methyl-4- mercaptobutyrimidate. Proc Natl Acad Sci 
USA 1974; 71:3946-3950. 
21. Molinari M, Helenius A. Analyzing cotranslational 
protein folding and disulfide formation by diagonal 
sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis. Methods Enzymol 2002; 348:35-42. 
22. Molinari M, Calanca V, Galli C, Lucca P, Paganetti P. 
Role of EDEM in the release of misfolded 
glycoproteins from the calnexin cycle. Science 2003; 
299:1397-1400. 
   
 
 






1) Amplification of the signal 
 
Mammalian tissue culture cells are seeded in 6-cm-diameter dishes (one dish for each chase time-point to be analyzed) 
the day before the experiment. Cells are grown in the appropriate cell culture medium in a 37°C humidified 5% CO2 
incubator.  
 
Transfection: Several transfection protocols are available depending on the transfection reagent and the cell line used 
for the experiments. Here is the protocol used in our lab for adherent mammalian cells. The day of the transfection 
cells have to be at 90-100% confluency. Cell culture media is replaced with 3 ml transfection media. The plasmid-of-
interest (4 µg) is diluted with 300 µl Optimem in a 5 ml plastic tube. In a second tube, 15 µl of Lipofectamine™ 2000 
are re-hydrated for 5 min in 300 µl Optimem. The solutions containing DNA and Lipofectamine™ 2000 are mixed and 
left 20 min at room temperature before addition to the cells. Pulse-chase experiment is usually performed the next day. 
 
Viral infection: Influenza virus (the model glycoprotein is then influenza hemagglutinin, HA), vesicular stomatitis 
virus (G protein and its temperature-sensitive mutant ts045 (18)) and Semliki forest virus (E1 and p62) have been 
widely used to characterize the secretory pathway. Each dish is first washed with PBS and then incubated at room 
temperature for 45 min-1 hr with 0.8 ml of inoculum. The inoculum is replaced with 2.5 ml/dish of cell culture 
medium and dishes are left for 4 additional hours at 37°C in a 5% CO2 incubator. 
 
2) Pulse-Chase (all steps at 37°C) 
 
Cells are washed with PBS (2 ml/dish) and starved in 1.5 ml/dish of starvation medium (15-30 min in a 5% CO2 
incubator). Dishes are then moved onto a non-floating rack placed in a water-bath. For metabolic labelling the 
starvation medium is replaced with 1 ml/dish of pulse medium. Metabolic labelling is stopped by addition of 1 ml 
chase medium quickly aspirated (aspirate in suitable flask to safely collect the radioactive medium) and chase is 
started by the addition of 2 ml/dish of chase medium.  
 
3) Sample alkylation and cell lysis (all steps at 4°C) 
 
After the selected chase time, each dish is transferred on ice and the chase medium is replaced with ice-cold PBS/20 
mM NEM (Stop solution). NEM is a cell-permeable alkylating agent that rapidly permeates in cells and blocks 
reactivity of free SH-groups of cysteines. Cells are incubated for 1-5 min in the stop solution. The solution is then 
aspirated as dry as possible before addition of 0.8 ml/dish of cell lysis buffer. When non-covalent interactions such as 
those often occurring between protein-of-interest and ER-resident molecular chaperones are investigated, an isotonic, 
buffered solution containing a protease inhibitors cocktail (CLAP and PMSF) and 2% CHAPS as detergent is 
preferred. CHAPS is a zwitterionic detergent that solubilizes plasma and endomembranes, whilst the nuclear 
membrane remains intact. After 20-30 min on ice, the cell lysate is collected in an Eppendorf tube and centrifuged at 
10600 g for 10 min to pellet the nuclei. The post nuclear supernatant (PNS) is aliquoted, snap-frozen in liquid nitrogen 
and stored at -80°C. 
 
Note: a) Several classes of detergents are used to solubilize biological membranes. 1. Ionic: used for the total 
disruption of a membrane and the dissociation of every component protein into monomers (e.g. Sodium dodecyl 
sulfate (SDS), an anionic detergent that denatures and inactivates most membrane proteins). 2. Non-ionic: used to 
solubilize membrane proteins in a much gentler fashion, often preserving native subunit structure and enzymatic 
   
 
 




activity (e.g. TRITON X-100®, Tween 20). 3. Zwitterionic (e.g. CHAPS). For a comprehensive review on solubilization 
of membranes by detergent please refer to (19). b) Calcium chelating agents such as EDTA should be avoided when 
association between the ER resident lectins calnexin and calreticulin with their substrates are investigated since these 
associations are calcium-dependent c) Association between the chaperone BiP/GRP78 and substrates is preserved by 
cell lysis only in the presence of 10 units/dish of Apyrase (Sigma) that rapidly depletes cellular ATP. 
 
4) Immunoprecipitation (all steps at 4°C) 
 
A fraction, usually 1:5-1:10 of the total PNS from each dish, is mixed with 100 µl PAB and an antibody specific for the 
protein-of-interest or for a selected chaperone to determine if this is associated with the protein-of-interest. Samples 
are incubated with slow rotation for 1-4 hr. PAB are then pelleted at 1800 g for 2 min in an Eppendorf centrifuge; the 
supernatant is aspirated with a flat-tip (unbound material to be discharged) and beads are resuspended in 1 ml of 
washing buffer. Samples are shaken for at least 5 min in Eppendorf tube shaker. Washing is repeated for 3 times. After 
the last wash, the washing solution is carefully aspirated and, for conventional SDS-PAGE, 30 µl of 3X sample buffer 
are added to the dry PAB. Samples are heated at 95°C for 5 min. Half of the sample is transferred in another 
Eppendorf tube containing 100 µMfin of DTT. For diagonal SDS-PAGE the samples are boiled in nonreducing sample 
buffer to be processed for first dimension capillary electrophoresis (see below). 
 
5) Conventional SDS-PAGE 
 
One mm thick polyacrylamide separating and stacking minigels are prepared, adjusting the acrylamide percentage to 
the apparent molecular weight of the protein-of-interest (e.g. for influenza virus HA, a glycoprotein of about 80 kDa 
we use 10% polyacrylamide gels, for Semliki Forest virus E1 (40 kDa) and p62 (60 kDa) we use 12% polyacrylamide 
gels). Allow at least 90 min of polymerization time before running the gels. When loading the gels note that at least 
one empty lane should separate nonreducing and reducing samples to avoid reduction of the former during the run. 
The empty lanes are filled with sample buffer. Gels are run at 200 V until the dye front exits (about 45 min). The gel is 
then stained with Coomassie blue for 5 min and destained until molecular weight markers and endogenous proteins 
(or antibody chains in case immunoprecipitates are analyzed) are clearly visible. Stain and destain solutions can be re-
used several times. The gel is dried on a 0.5 mm Whatman filter paper in a vacuum/heated gel dryer and exposed to 
film or to a Phosphor imaging screen. Overnight exposures are often sufficient to clearly distinguish labelled 
polypeptides. 
 
6) Diagonal SDS-PAGE 
 
Diagonal gels are 2D gels originally used to analyze chemically cross-linked ribosomal components (20) and 
subsequently adapted to investigate cotranslational events and oxidative phases of glycoprotein folding (reviewed in 
(21)). The first dimension is run under nonreducing conditions in a glass capillary tube of 7 cm length and an internal 
diameter of 1.3 mm. For the second dimension, the gel is extruded from the glass tube, boiled in reducing sample 
buffer and placed onto a conventional slab gel. 
 
First dimension: capillary glass tubes are washed with ethanol and, then distilled water and then dried in an oven for 
at least 1 hr at 70°C or at room temperature for at least 24 hr. Ten tubes are put in a plastic cylinder few millimeters 
shorter than the capillary tubes themselves, to facilitate manipulations. The tube can easily be prepared by cutting 
with a knife the bottom of a 15 ml Falcon. The Falcon’s lid is then the base of the cylinder. The acrylamide solution 
prepared as for a normal nonreducing SDS-PAGE is poured rapidly after addition of ammonium persulfate and 
TEMED in the plastic cylinder (it enters the glass tubes per capillarity, from the bottom). A few µl of isobutanol or 
distilled water is carefully added to the above gels in each capillary tube and polymerization is allowed for at least 90 
   
 
 




min. The isobutanol or water is replaced with 30 µl of stacking gel/capillary tube. The capillary tubes can be stored for 
several weeks at 4°C in a humid chamber.  
 
The first dimension is run in a BioRad 2D gel system according to the manufacturer’s instructions. The glass capillary 
tubes are attached to the sample-reservoir with flexible plastic tube connectors. The lower tank is filled with 
approximately 800 ml of SDS-PAGE running buffer. Air bubbles are carefully removed from the tubes and samples 
are loaded with a Hamilton syringe (for better resolution, not more than 15 µl of sample are loaded). The first 
dimension is run at 100 V, in a cold room to avoid excessive heating of the capillary tubes, until the blue front runs 
out. At the end of the run, the gel is carefully extruded from the glass capillary tube using a tube gel ejector (BioRad) 
connected to a syringe filled with running buffer. The capillary gel is boiled for 10 min in an Eppendorf tube 
containing 800 µl of reducing sample buffer.  
 
For the second dimension the capillary gel is carefully slid between the glass plates of a conventional slab gel with the 
help of a clean spatula. The second dimension is run at 200 V constant voltage until the dye front reaches the bottom 
of the gel. The gel is stained with Coomassie blue for 5 min, destained and dried on a 0.5 mm Whatman filter paper. 
The gel is then exposed on Biomax film. Very little radioactivity is incorporated in growing nascent chains, thus long 
exposures are often required. 
